Positive results from additional analyses of PRIDE-HD and Open-HART trials with pridopidine published in a peer-reviewed journal, The Journal of Huntington's Disease. Exploratory additional efficacy ...
Positive results from additional analyses of PRIDE-HD and Open-HART trials with pridopidine published in peer-reviewed journal, The Journal of Huntington’s Disease. Exploratory additional efficacy ...
NAARDEN, Netherlands--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback